Bristol Myers Squibb
-
Antitrust litigation against Dr Reddy’s Laboratories, Celgene and Bristol-Myers Squibb in US
The complaint has asked for equitable redress and damages for alleged over payments An antitrust lawsuit was filed in the…
Read More » -
Syngene International extends research collaboration with Bristol Myers Squibb until 2030
The extension envisions a 40 per cent increase in the number of scientists and the addition of a new 50,000…
Read More » -
FDA delays decision on Bristol Myers cancer therapy
Coronavirus-related travel restrictions is the reason for the delay Bristol Myers Squibb said that the US health regulator has deferred…
Read More » -
Bristol Myers psoriasis drug succeeds in late-stage study
The drug, deucravacitinib, met both main goals of the study by reducing the extent and severity of psoriasis after 16…
Read More » -
Syngene International joins global industry consortium
Syngene International has joined a global consortium of 19 organisations from the healthcare industry, led by Bristol Myers Squibb, to…
Read More »
